Clinical trial
Safety of RG2077 in Patients With Multiple Sclerosis
NCT00076934
Study timeline
Study start (unknown)2003-01-01Date precision: month
Registry last updated2017-03-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Multiple Sclerosis, Relapsing-Remittingunresolved
Interventions
Sponsors & collaborators
Immune Tolerance Network (ITN)collaborator
Repligen Corporationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00076934 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.